Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Data on the prevalence and complications of gestational diabetes are very scarce in Cameroon. The aim of this study was to evaluate the uptake of screening for gestational diabetes and assess the immediate post-partum outcome of hyperglycemic parturient mothers and perinatal outcome of their babies.

Methods: A prospective cohort study was held at the Maternity of the Yaoundé Central Hospital from March to June 2013. One hundred volunteer women in labor without overt diabetes mellitus and having fasted for 8 to 12 h were recruited. No intervention was given. A clinical examination was done and capillary glucose recorded. Parturient women were categorized into two groups (hyperglycemic and non-hyperglycemic subjects) based on glycemia results interpreted according to the International Association of Diabetes and Pregnancy Study Groups. Mothers' clinical examination was repeated and neonates examined immediately after delivery. Perinatal outcomes associated with maternal hyperglycemia during labor were assessed using relative risks. A p value <0.05 was considered statistically significant.

Results: One hundred women with a mean age of 27 (SD 6) years were recruited. Of them, 22 (22 %) had already been screened for gestational diabetes at baseline. Thirty-one (31 %) were diagnosed with hyperglycemia during labor, and this condition was highly associated with macrosomia in neonates (RR = 8.9, 95 % CI 2.70-29.32; p < 0.001). Other complications associated with maternal hyperglycemia during labor were perineal tears, cesarean section, and intrauterine fetal death, though the association was not statistically significant.

Conclusions: The main finding of this study is that maternal hyperglycemia during labor is highly associated with macrosomia in neonates. About a third of mothers were concerned with hyperglycemia during labor, and gestational diabetes was insufficiently screened in this series.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5026003PMC
http://dx.doi.org/10.1186/s41043-016-0065-xDOI Listing

Publication Analysis

Top Keywords

maternal hyperglycemia
8
hyperglycemia labor
8
perinatal outcomes
8
yaoundé central
8
central hospital
8
gestational diabetes
8
clinical examination
8
labor post-partum
4
post-partum maternal
4
maternal perinatal
4

Similar Publications

Senescence-regulating agents remodel mesenchymal stem cell-schwann cell circuitry for diabetic bone regeneration.

Biomaterials

August 2025

Department of Oral and Cranio-maxillofacial Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, College of Stomatology, Shanghai Jiao Tong University, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Shanghai Key Laborator

Bone healing requires Schwann cells (SCs) paracrine factors for mesenchymal stem cell function. Diabetes mellitus (DM) patients are susceptible to developing SCs dysfunction and impairing bone healing. Rare research considered reconstructing mesenchymal stem cell-schwann cell circuitry in diabetic bone regeneration.

View Article and Find Full Text PDF

Background: Fasting during Ramadan poses distinct challenges for individuals with diabetes, especially pregnant women, due to increased metabolic demands and the heightened risk of hypoglycemia, hyperglycemia, and dehydration. Although medical guidelines often advise against fasting in this group, many women still choose to observe the fast. This study aims to explore diabetes self-efficacy and self-care behaviors during and after Ramadan among pregnant women.

View Article and Find Full Text PDF

Inpatient hyperglycemia remains a challenge, as conventional insulin regimens often lead to both hyperglycemia and hypoglycemia. Traditional glucose monitoring methods, such as point-of-care testing, fail to detect diurnal and nocturnal glycemic fluctuations, contributing to suboptimal control. This review examines the effectiveness of continuous glucose monitoring (CGM) and automated insulin delivery (AID) systems in managing diabetes in hospitalized patients, including those with additional challenges such as end-stage kidney disease (ESKD), pregnancy, and steroid use.

View Article and Find Full Text PDF